ClinicalTrials.gg
TerminatedNCT03484208Updated Apr 28, 2023

Evaluation of a Fracture Liaison Service in the Osteoporosis Care

An observational study in Osteoporotic Fractures, sponsored by Fondation Hôpital Saint-Joseph. Terminated at 1 site in France. Open to participants aged 45 Years to 95 Years. Per ClinicalTrials.gov, last updated 2023-04-28.

Sponsored by Fondation Hôpital Saint-Joseph · Observational

Why this study was terminated
PI's choice

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
346
Ages
45 Years to 95 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 10 studies in Osteoporotic Fractures with a site in France — 2 open to participants now, 3 under way, none of them phase 3. Osteoporotic Fractures · France.

Started
2018
with 2 others
Observational
6 of 10
2 open now
Registered
3rd of 10
by date
Lead sponsor
4 of 10
Fondation Hôpital Saint-Joseph

Among the 10 studies in Osteoporotic Fractures with a site in France, this one is one of 3 that started in 2018, is one of 6 observational ones, and was the 3rd registered.

Osteoporotic Fractures

87 studies on the registry are indexed under Osteoporotic Fractures; 22 are open to participants now.

Browse Osteoporotic Fractures studies →

Open to participants now

2 of the 10 studies in Osteoporotic Fractures with a site in France are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 14 Osteoporotic Fractures studies recruiting now, 9 (64%) set no upper age limit and none (0%) stop at 75 or younger; 1 takes children under 18; 2 take healthy volunteers.

This study: 45 Years to 95 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Osteoporotic Fractures with a site in France, or all of them as a file.
02

Study summary

The St JOSEPH'S HOSPITAL set up a fracture liaison service for osteopotic fracture. A specific nurse screens eligible patient admitted in emergency yard and call them to propose a bone densitometry and a medical coverage..

The aim of the study is to evaluate this new organisation

03

Conditions studied

  • Osteoporotic Fractures

Browse trials for

04

Who can participate

Ages eligible
45 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients admitted in emergency yard for low energy fracture

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 45 and 95 years old.
  • Admitted in emergency yard for law energy trauma

Exclusion criteria

Exclusion Criteria:

  • feet fracture
  • fracture on prothesis
  • patient transferred elsewhere
  • homeless people
  • patient with lot of comorbidities
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
346 participants (actual)
Patient registry
No

Interventions

  • Otherosteoporotic fracture liaison service

    a specific nurse calls patient and propose them to follow the osteoporotic fracture liaison service

06

What researchers measure

Primary outcomes

  1. valuable osteoporosis care

    valuable osteoporosis care means a bone densitometry for minor fracture and a medical treatment for major fracture

    Time frame: Month 1

07

Study locations

1 site
  • Groupe Hospitalier Paris Saint Joseph
    Paris, Ile-de-France 75014, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2018 to primary completion in Aug 2018, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2018
First posted
Mar 30, 2018
StartActual
Feb 8, 2018
Primary completionActual
Aug 7, 2018
CompletionActual
Apr 26, 2023
Last update
Apr 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03484208
Responsible party
Sponsor
First posted
Mar 30, 2018
Start date
Feb 8, 2018
Primary completion
Aug 7, 2018
Completion
Apr 26, 2023
Last update
Apr 28, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion